Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDStarling Oncolog Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2026 | 3 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2026 | 3 | -$0.05 | -$0.05 | -$0.05 |
| Q4 2026 | 3 | -$0.01 | -$0.01 | -$0.01 |
| Q1 2027 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2027 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2027 | 1 | $0.02 | $0.02 | $0.02 |
| Q4 2027 | 1 | $0.03 | $0.03 | $0.03 |
| Q1 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 2 | $0.00 | $0.00 | $0.00 |
Starling Oncolog Earnings Date And Information
Starling Oncolog last posted its earnings results on Thursday, August 6th, 2026. The company reported $-0.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.064 by $0.016. The company had revenue of 161.28 M for the quarter and had revenue of 502.73 M for the year. Starling Oncolog has generated $-1 earnings per share over the last year ($-0.54 diluted earnings per share) and currently has a price-to-earnings ratio of -22.17. Starling Oncolog has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Starling Oncolog Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/30/2026 | Q2 2026 | N/A | -$0.08 | N/A | $155.74 M | $161.28 M |
| 03/31/2026 | Q1 2026 | N/A | -$0.02 | N/A | $142.10 M | $147.44 M |
| 12/31/2025 | Q4 2025 | N/A | -$0.06 | N/A | $139.79 M | $141.96 M |
| 09/30/2025 | Q3 2025 | N/A | -$0.14 | N/A | $122.63 M | $136.56 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Starling Oncolog Earnings: FAQ's
The conference call for Starling Oncolog's latest earnings report can be listened to online.
The conference call transcript for Starling Oncolog's latest earnings report can be read online.
Starling Oncolog (:STLN) has a recorded annual revenue of $502.73 M.
Starling Oncolog (:STLN) has a recorded net income of $-60,606,000.Starling Oncolog has generated $-0.54 earnings per share over the last four quarters.
Starling Oncolog (:STLN) has a price-to-earnings ratio of -22.17 and price/earnings-to-growth ratio is 0.33.